This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chilton, L. Articles by Loutzenhiser, R. Search for Related Content PubMed PubMed Citation Articles by Chilton, L. Articles by Loutzenhiser, R. Related Collections Cell signalling/signal transduction Ion channels/membrane transport

(Circulation Research. 2001;88:152.)
© 2001 American Heart Association, Inc.

Integrative Physiology

Functional Evidence for an Inward Rectifier Potassium Current in Rat Renal Afferent Arterioles

Lisa Chilton, Rodger Loutzenhiser

From the Department of Pharmacology and Therapeutics, University of Calgary, Calgary, Alberta, Canada.

Correspondence to Rodger D. Loutzenhiser, PhD, Department of Pharmacology and Therapeutics, University of Calgary, Health Sciences Centre, 3330 Hospital Dr NW, Calgary, Alberta T2N 4N1, Canada. E-mail rloutzen{at}ucalgary.ca

	Abstract

Top Abstract Introduction Materials and Methods Results Discussion References

 
Abstract—An inward rectifier potassium current, Kir, has been identified in cerebral and coronary resistance vessels, where it is considered to be an important determinant of resting membrane potential (RMP) and to play a role in blood flow regulation. We investigated the functional role of Kir in the renal afferent arteriole using the in vitro–perfused hydronephrotic rat kidney. Increasing external KCl from 5 to 15 mmol/L induced afferent arteriolar vasodilation. This response was inhibited by 10 to 100 µmol/L Ba²⁺, concentrations selective for blockade of Kir, and by chloroethylclonidine (100 µmol/L) but was not blocked by glibenclamide (10 µmol/L) or ouabain (3 mmol/L). Reducing external KCl from 5 to 1.5 mmol/L to enhance rectification of Kir caused vasoconstriction at low renal arterial pressure (40 mm Hg) and vasodilation during myogenic vasoconstriction (120 mm Hg), suggesting that this current dominates RMP at low perfusion pressures. When administered to kidneys perfused at 40 mm Hg renal arterial pressure, 30 µmol/L Ba²⁺ elicited afferent arteriolar depolarization, reducing RMP from -47±2 to -34±2 mV (n=10, P<0.0001), and vasoconstriction, reducing diameters from 14.5±1 to 10.9±0.8 µm (n=10, P=0.0016). Although Ba²⁺ reduced resting diameter, blockade of Kir did not prevent myogenic signaling in this vessel. Our findings thus demonstrate the presence of Kir in rat renal afferent arterioles and suggest that this current is an important determinant of RMP in situ.

Key Words: renal hemodynamics • renal microcirculation • membrane potential • barium • ouabain

	Introduction

Top Abstract Introduction Materials and Methods Results Discussion References

 
Of the 4 classes of K⁺ channels known to regulate vascular smooth muscle tone, the inward rectifier, Kir, is the least characterized. This is attributable in part to its restricted expression in resistance vessels. Kir is absent in most large conduit vessels. However, the density of Kir and its physiological importance may increase with decreasing vessel caliber.^{1 2 3} Although Kir has been identified in submucosal,⁴ carotid,⁵ cerebral,^{2 6} and coronary arteries,⁶ the role of Kir in the renal microcirculation has not been studied. Prior et al⁷ concluded that Kir does not play a functional role in regulation of tone in rabbit renal arcuate arteries. However, the arcuate is not a resistance vessel. Renal vascular resistance is determined predominantly by the afferent and efferent arterioles.⁸ The afferent arteriole is the terminal resistance vessel upstream of the glomerulus and, by regulating preglomerular resistance, plays the major role in renal autoregulation and the control of glomerular capillary pressure.

K⁺-induced vasodilation has long been recognized as a mechanism for regulating local blood supply. In general, modest increases in local K⁺ concentration result in vasodilation and increased blood flow.⁹ This vasodilation is mediated, in part, by the outward current carried by Kir. Patch-clamp studies using smooth-muscle myocytes from vessels exhibiting K⁺-induced dilation demonstrate that elevations in external K⁺ increase outward current through Kir.^{10 11 12} This effect is attributable to a displacement by K⁺ of polyamine or Mg²⁺ binding within the pore, which reduces rectification and increases outward current.¹³ An alternate mechanism whereby external K⁺ can induce vasodilation is by stimulating the ouabain-sensitive, electrogenic Na⁺-K⁺ ATPase.^{6 7 14} Ba²⁺ blocks Kir at micromolar concentrations and can be used to distinguish Kir-induced vasodilation from effects mediated by other K⁺ channels or from ouabain-sensitive vasodilation.^{10 11 12 14} In addition, the -adrenoceptor agonist/antagonist chloroethylclonidine (CEC) has recently been shown to block Kir.¹⁵ Hence, the combination of K⁺-induced vasodilation together with micromolar sensitivity to Ba²⁺ and lack of effect of ouabain provides reasonable evidence for a functional role of Kir in intact vessels.

In the present study, the role of Kir in the renal afferent arteriole was investigated using the in vitro–perfused hydronephrotic rat kidney preparation.¹⁶ We determined the ability of 15 mmol/L KCl to dilate the afferent arteriole and the effects of Ba²⁺, CEC, and ouabain on this response. The contribution of Kir to resting membrane potential (RMP) was assessed by simultaneously measuring afferent arteriolar RMP and diameter during blockade of Kir. Finally, we examined the impact of blocking Kir on myogenic reactivity. Our findings provide the first evidence of a functional role for Kir in the renal microcirculation.

	Materials and Methods

Top Abstract Introduction Materials and Methods Results Discussion References

 
The in vitro hydronephrotic rat kidney¹⁶ was used to examine the role of Kir in the afferent arteriole. Use of animals complied with Canadian Council on Animal Care regulations. Unilateral hydronephrosis was induced in male Sprague-Dawley rats by ligating the left ureter under halothane anesthesia. Rats were obtained from the Animal Resource Center breeding facility at the University of Calgary. Kidneys were harvested after 6 weeks, when tubular atrophy had advanced to a stage allowing direct visualization of the renal microvasculature. The renal artery was cannulated, and the kidney was excised with continuous perfusion. Kidneys were perfused with modified DMEM (GIBCO) at 37°C, equilibrated with 5% CO₂, containing (in mmol/L) Ca²⁺ 1.6, bicarbonate 30, glucose 5, pyruvate 1, and HEPES 5. Endogenous prostanoids modulate vascular reactivity in both normal kidneys and in our model.¹⁶ Therefore, 10 µmol/L ibuprofen was included in the perfusate. Perfusion pressure was monitored at the level of the renal artery and was controlled by adjusting pressure within the perfusion reservoir. Kidneys were allowed 1 hour to recover before initiation of experimental protocols. Diameters were measured by online image processing.

Afferent arteriolar RMPs were measured as described previously.¹⁷ Hydronephrotic kidneys were excised as described above. The capsule was removed, and the perfused kidney was mounted on a Plexiglas post, allowing access to the surface. A custom microscope with a water-immersion ceramic objective, coupled to a projection lens and video system, provided high magnification for impalements and diameter measurements. A microelectrode (2 mmol/L KCl and beveled at 30° to 80 to 100 M) was placed within a patch-type pipette (tip diameter 10 to 20 µm) using a custom holder with motorized positioner. The patch pipette was then positioned against the vessel wall and held with suction to stabilize the impalement site. A piezo device was used to impale the vessel. We have shown that RMP measurements obtained using this approach are similar to those obtained using conventional microelectrodes.¹⁷ An impalement was considered successful if each of the following criteria were met: sudden negative deflection in membrane potential, stable recording of membrane potential for at least 1 minute before treatment with Ba²⁺, and no change in microelectrode tip resistance on withdrawal. The effects of Ba²⁺ on RMP and diameter were recorded simultaneously using this approach.

Glibenclamide and ibuprofen were obtained from Research Biochemicals International. All other chemicals were obtained from Sigma. KCl solutions 10 and 15 mmol/L were prepared by isotonic substitution for NaCl. Ouabain was made fresh for each experiment (3 mmol/L in DMEM). Phentolamine and propranolol were added during the ouabain experiment to avoid effects mediated by neurotransmitter release and to the CEC experiments to avoid effects of adrenoceptor modulation.

Data are expressed as mean±SEM. The number of replicates (n) refers to the number of vessels. Generally, no more than 2 vessels were studied per kidney (where appropriate, N refers to number of kidneys). Differences between means were evaluated by Student’s paired t test unless otherwise noted. P<0.05 was considered significant.

	Results

Top Abstract Introduction Materials and Methods Results Discussion References

 
Figure 1 illustrates the vasodilator response of an afferent arteriole to 15 mmol/L KCl. Vasoconstriction was induced by elevating renal arterial pressure (RAP) from 80 to 160 mm Hg, reducing diameters from 16.3±0.4 to 8.1±0.5 µm (n=25, P<0.0001). In this setting, 15 mmol/L KCl caused afferent arteriolar dilation to 13.6±0.5 µm (P<0.0001). Returning to 5 mmol/L KCl restored myogenic vasoconstriction to previous levels (8.5±0.5 µm, P=0.26).

View larger version (29K): [in this window] [in a new window]   Figure 1. K+-induced dilation of afferent arterioles. A, Original tracing illustrating RAP-induced vasoconstriction and K+-induced dilation in the afferent arteriole. B, Summary of data obtained in 25 arterioles subjected to the protocol illustrated in panel A. *P<0.0001 vs elevated RAP alone.

We next assessed the effects of Ba²⁺ and CEC on K⁺-induced vasodilation. The control studies presented in Figure 2A illustrate that repetitive K⁺-induced responses were stable over time. As shown in Figure 2B, Ba²⁺ attenuated this response in a concentration-dependent manner. Ba²⁺ also reduced basal diameters (considered in detail below), precluding a calculation of the ED₅₀. Nevertheless, Ba²⁺ reduced the K⁺-induced dilation over concentrations that selectively block Kir^{10 11 12} (10 to 100 µmol/L). Complete blockade was observed at 100 µmol/L (P=0.54, n=6). At 100 µmol/L, Ba²⁺ may block ATP-sensitive K⁺ channels (K_ATP).¹⁴ However, glibenclamide had no effect. Thus, 15 mmol/L KCl increased diameters from 8±1.4 to 15.1±2.1 µm in the presence of vehicle (ethanol) and from 8.3±2.6 to 15.1±2.5 µm in the presence of 10 µmol/L glibenclamide (n=3, P=0.9). The K⁺-induced dilation was also blocked by 100 µmol/L CEC, an agent recently shown to block Kir¹⁵ (Figure 2C). Before application of CEC, 15 mmol/L K⁺ induced dilation in preconstricted arterioles (9.5±1.6 versus 15.5±0.9 µm with 15 mmol/L KCl, RAP=140 mm Hg, n=5). CEC caused additional constriction, reducing diameters to 6.4±1.1 µm, and completely blocked the K⁺-induced dilation. Notably, application of 15 mmol/L KCl during CEC treatment caused additional constriction (to 4.9±1.1 µm, n=5), consistent with the change in the K⁺ equilibrium potential.

View larger version (24K): [in this window] [in a new window]   Figure 2. Barium and CEC blockade of K+-induced vasodilation. A, Time controls illustrating reproducible vasodilatory response of 4 vessels to 6 consecutive challenges with 15 mmol/L KCl. B, Effects of Ba2+ on K+-induced vasodilation. Ba2+ decreased basal diameter and blocked K+-induced vasodilation in a concentration-dependent manner (1, 3, 10, 30, and 100 µmol/L; , , , , and , respectively; n=6). C, Blockade of K+-induced dilation by 100 µmol/L CEC. Propranolol and phentolamine (10 µmol/L) were present to prevent adrenoceptor-mediated effects.

The above findings suggest that the K⁺-induced dilation is mediated by Kir on the basis of the effects of Ba²⁺ and CEC. We next examined the effects of blockade of the Na⁺-K⁺ ATPase. Vessels were preconstricted by administering 3 mmol/L ouabain (RAP 80 mm Hg), a concentration sufficient to block the rat isoform.¹⁴ Kidneys were pretreated with phentolamine and propranolol (10 µmol/L) to prevent effects attributable to the release of neurotransmitters. As shown in Figure 3, ouabain reduced diameters from 16.3±1.5 to 4.2±1.5 µm (n=4, P=0.022), but K⁺-induced vasodilation was preserved (increasing diameters from 4.2±1.5 to 13.7±0.9 µm, P=0.0246). In these studies, 10 mmol/L KCl was used to allow for the decrease in internal [K⁺] induced by ouabain. When kidneys were treated with both 100 µmol/L Ba²⁺ and ouabain, diameters decreased from 18±0.9 to 3.8±1 µm (n=4, P=0.0033), and KCl-induced dilation was blocked (3.9±1.2 µm, P=0.56). The ability of Ba²⁺ to block KCl-induced dilation was readily reversed when Ba²⁺ was removed from the perfusate (Figure 4A).

View larger version (26K): [in this window] [in a new window]   Figure 3. Lack of effect of ouabain on K+-induced vasodilation. Tracings illustrate K+-induced vasodilation in afferent arteriole preconstricted with 3 mmol/L ouabain (A) and blockade of this response by 100 µmol/L Ba2+ (B). Mean data are depicted in panel C (n=4 each). All studies carried out in the presence of 10 µmol/L phentolamine and propranolol.

View larger version (27K): [in this window] [in a new window]   Figure 4. Tracings illustrating reversibility of Ba2+-induced inhibition of KCl-induced vasodilation (A) and Ba2+-induced vasoconstriction (B). A, indicates exposure to 15 mmol/L KCl. Data representative of 3 replicates each.

Kir is thought to contribute to RMP and resting tone in other vessel types.^{10 11 12} We thus determined the effects of Ba²⁺ blockade of Kir on resting diameter and RMP in the afferent arteriole. As shown in Figure 4B, Ba²⁺ elicited a vasoconstrictor response of the afferent arteriole that was reversed on Ba²⁺ removal. Ba²⁺ blockade of Kir elicited dose-dependent vasoconstriction over concentrations of 1 to 100 µmol/L. At 80 mm Hg, 30 µmol/L Ba²⁺ reduced afferent arteriolar diameter from 15.6±0.5 to 7.6±1.6 µm (51±9% decrease, n=6, P=0.0041). Half-maximal constriction (EC₅₀) was seen at 19±3 µmol/L Ba²⁺ (Figure 5). As described below, Ba²⁺ altered the threshold for myogenic vasoconstriction, shifting the response to lower pressures. We therefore characterized the effects of Ba²⁺ at low perfusion pressure (40 mm Hg). Under these conditions, 30 µmol/L Ba²⁺ reduced RMP from -47±2 to -34±2 mV (P<0.0001) and reduced diameter from 14.5±1 to 10.9±0.8 µm (n=10, N=8, P=0.002). These data are summarized in Figure 6.

View larger version (15K): [in this window] [in a new window]   Figure 5. Ba2+-induced constriction in afferent arterioles (mean±SEM, n=6). *P<0.05 vs control. EC50=19±3 µmol/L; RAP=80 mm Hg.

View larger version (25K): [in this window] [in a new window]   Figure 6. A, Original tracings of membrane potential and diameter of an afferent arteriole during the administration of 30 µmol/L Ba2+. B, Ba2+ (30 µmol/L)-induced depolarization (left) and vasoconstriction (right) in afferent arterioles perfused at a renal arterial pressure of 40 mm Hg. , individual measurements; •, mean±SEM (n=10). C, Summary of individual measurements.

These findings suggest an important role of Kir in the setting of RMP and basal tone in the afferent arteriole. However, this interpretation is based exclusively on the premise that 30 µmol/L Ba²⁺ selectively blocks Kir. To independently test this postulate, we examined the effects of reducing external K⁺ ([K⁺]_o). The inward rectification that is characteristic of Kir is attributed to polyamine or Mg²⁺ block. Elevated [K⁺]_o reduces rectification by displacing these blocking agents and enhancing outward current, thereby causing vasodilation.^{10 11 12 13} Conversely, reducing [K⁺]_o will enhance the effects of the blocking agents and reduce outward current carried by Kir. Thus, if Kir is the predominant K⁺ channel influencing RMP, then reducing [K⁺]_o should cause vasoconstriction. On the other hand, reducing [K⁺]_o shifts the K⁺ equilibrium potential to more negative values and will enhance the hyperpolarizing current carried by other K⁺ channel types. Kir is the only K⁺ channel in vascular smooth muscle in which reduced [K⁺]_o would enhance intrinsic block. Hence, if K⁺ channels other than Kir are dominant, reducing [K⁺]_o would cause vasodilation, not vasoconstriction. As shown in Figure 7, reducing [K⁺]_o from 5 to 1.5 mmol/L induced a constriction at 40 mm Hg, reducing diameters from 15±0.6 to 12.8±0.9 µm (n=6, N=5, P=0.0088). To rule out the possibility that lowering [K⁺]_o induced vasoconstriction by reducing activity of the electrogenic Na⁺-K⁺ ATPase, we conducted additional experiments in the presence of 3 mmol/L ouabain. The ouabain-induced vasoconstriction was minimized by reducing RAP to 30 mm Hg. In the presence of ouabain, lowering [K⁺]_o from 5 to 1.5 mmol/L caused additional constriction, reducing diameters from 14±8.2 to 8.2±1.2 µm (P=0.0014, n=5). We next examined the effects of lowering [K⁺]_o at elevated RAP, conditions in which channels other than Kir, such as voltage- or Ca²⁺-activated K⁺ channels (Kv and K_Ca), might be active. We have shown that K_Ca is activated at elevated pressure, modulating myogenic vasoconstriction.¹⁸ Elevating RAP from 80 to 120 mm Hg reduced afferent diameters from 15.8±0.8 to 9.9±0.8 µm (n=6, P=0.0008). In this setting, reducing [K⁺]_o to 1.5 mmol/L increased diameters from 9.9±0.8 to 14.1±0.5 µm (n=6, P=0.0006). In concert with the Ba²⁺ data, these observations provide compelling evidence that Kir is the predominant K⁺ channel responsible for setting resting afferent arteriolar tone at low levels of perfusion pressure.

View larger version (23K): [in this window] [in a new window]   Figure 7. Effects of reducing [K+]o on afferent arteriolar diameter. Left panel depicts original tracings illustrating the vasoconstriction evoked by 1.5 mmol/L KCl at 40 mm Hg (top) and the vasodilation evoked in the same vessel at 120 mm Hg (bottom). Mean data (±SEM) depicted on right.

Accordingly, alterations in Kir might contribute to myogenic activation. Therefore, we examined the effects of Ba²⁺ on the myogenic response. As shown in Figure 8A, graded afferent vasoconstriction is elicited when RAP is increased from 20 to 180 mm Hg. Figure 8A additionally illustrates that in a series of time controls, 6 repeated challenges to increased renal arterial pressure (administered over a 7-hour period) elicited identical myogenic responses (n=4). As shown in Figure 8B, 1 to 100 µmol/L Ba²⁺ elicited vasoconstriction at low RAP but did not prevent additional constriction when RAP was increased. This is additionally illustrated in Figure 8C, which depicts the response as the percent change in diameter. Ba²⁺ caused a leftward shift in the activation curve, perhaps reflecting the impact of blockade of Kir on basal tone and RMP. However, despite the Ba²⁺-induced preconstriction, the arterioles responded in an incremental manner to elevations in RAP, suggesting that Kir modulation is not a requisite component of myogenic signaling in this vessel.

View larger version (29K): [in this window] [in a new window]   Figure 8. Effect of Ba2+ on the myogenic response. A, Time controls illustrating reproducible responses of 4 arterioles to 6 consecutive challenges with stepped elevation in RAP. B, Increasing concentrations of Ba2+ (1, 3, 10, 30, and 100 µmol/L; , , , , and , respectively) elicited vasoconstriction at low RAP and augmented the maximal response to RAP (controls, •; n=6). C, Data from panel B expressed as percent change relative to the diameter at 40 mm Hg. Increasing Ba2+ concentrations elicited a leftward shift in the pressure-activation curve.

	Discussion

Top Abstract Introduction Materials and Methods Results Discussion References

 
The present study provides the first evidence for a functional role of Kir in the renal afferent arteriole. We demonstrated that 15 mmol/L KCl elicits a vasodilation in this vessel and that this response was not prevented by ouabain but was sensitive to CEC and Ba²⁺ at concentrations reported to selectively block Kir. Moreover, manipulations that would reduce Kir currents under basal conditions (30 µmol/L Ba²⁺, low [K⁺]_o) elicit both depolarization and vasoconstriction, suggesting that Kir is a significant determinant of RMP and resting tone in the afferent arteriole.

The properties of the K⁺-induced dilation in the afferent arteriole are similar to those attributed to Kir in other vessel types. Application of 6 to 16 mmol/L KCl to preconstricted isolated posterior cerebral arteries,^{6 14} middle cerebral arteries,¹⁹ and coronary arteries⁶ results in dilation, and this response is blocked by micromolar levels of Ba²⁺. In these preparations, as in the present study, neither ouabain nor glibenclamide prevented this response. Electrophysiological characterization of Kir in vascular smooth muscle was first reported by Hirst and Neild,⁴ who described currents exhibiting inward rectification in submucosal arterioles of guinea pig ileum. Similar inwardly rectifying currents have been described in carotid artery⁵ and middle cerebral arteriole.^{20 21} Studies using patch-clamp techniques have identified K⁺-induced increases in outward current and inhibition of this current by micromolar Ba²⁺ in myocytes isolated from posterior cerebral artery^{2 6} and coronary artery.^{3 6 22} Recently, the targeted disruption of the Kir2.1 gene in mice was shown to be associated with a loss of both the inwardly rectifying K⁺ current and K⁺-induced dilation in cerebral arteries, suggesting its essential role in the response.²³ Our finding that CEC inhibited K⁺-induced vasodilation additionally supports a role for Kir. CEC is an irreversible agonist at ₂ adrenoceptors and an antagonist at ₁ adrenoceptors²⁴ but was recently reported to selectively inhibit inward rectifier K⁺ currents in skeletal muscle fibers and whole-cell K⁺ currents in cultured cell lines transfected with Kir2.1.¹⁵ These effects did not involve adrenoceptors, because they were not mimicked or altered by adrenoceptor ligands and could be demonstrated in cells that do not express adrenoceptors.¹⁵ Similarly, the inhibition of K⁺-induced dilation by CEC in the afferent arteriole that we observed occurred in the presence of phentolamine and propranolol, indicating that adrenoceptors are not involved.

Two previous studies have addressed the possible role of Kir in the renal circulation. Kurtz and Penner²⁵ described inward rectifying K⁺ currents in mouse juxtaglomerular cells, renin-secreting cells in the terminal segment of the afferent arteriole. They recorded whole-cell currents that were sensitive to changes in external K⁺ but did not assess Ba²⁺ sensitivity. More recently, Prior et al⁷ evaluated the Ba²⁺ and ouabain sensitivity of K⁺-induced dilation of rabbit renal arcuate arteries. In contrast to our findings with the afferent arteriole, these authors found that K⁺-induced dilation of the arcuate artery was attenuated by ouabain but not blocked by Ba²⁺, suggesting that Kir is not involved. As mentioned previously, Kir is thought to be more prevalent in resistance vessels than in conduit arteries, such as the arcuate artery. Our findings, together with those of Prior et al,⁷ indicate that this pattern holds in the kidney.

In our studies, 30 µmol/L Ba²⁺ produced marked constriction of the afferent arteriole and membrane depolarization (13 mV) at low RAP, suggesting a role for Kir in maintaining RMP and resting tone. A more modest Ba²⁺-induced constriction (8%, from 208±7 to 191±19 µm with 120 µmol/L Ba²⁺) was described in isolated perfused rat middle cerebral arteries by Johnson et al.¹⁹ In our studies, Ba²⁺ inhibited K⁺-induced vasodilation at 10 to 100 µmol/L and elicited vasoconstriction in the same concentration range (ED₅₀=19±3 µmol/L). The ED₅₀ for Ba²⁺-induced vasoconstriction in the middle cerebral artery is 60 µmol/L (see Figure 6 in Johnson et al). Similarly, the IC₅₀ for Ba²⁺ block of K⁺-induced dilation in middle cerebral arteries was 20 to 40 µmol/L (see Figure 3 in Johnson et al¹⁹ ). These values are close to the range for Ba²⁺ blockade of Kir channels. At -45 mV, the K_d for Ba²⁺-induced inhibition of Kir in posterior cerebral artery myocytes was estimated at 8 µmol/L.^{2 6} Similar K_d values, 3 µmol/L⁶ Ba²⁺ and 4.7 µmol/L²² Ba²⁺ at -40 mV, were reported for coronary artery myocytes.

K⁺-induced vasodilation is an important physiological mechanism in the cerebral and coronary circulations but has not been studied in the renal circulation. Periods of high neural activity, such as seizure, and ischemic, hypoxic, or hypoglycemic conditions increase K⁺ levels in cerebral spinal fluid to >10 mmol/L.²⁶ The resultant K⁺-induced dilation increases blood supply to areas of high metabolic demand.¹⁴ Similarly, in the coronary circulation, interstitial K⁺ levels may rise during periods of ischemia to levels sufficient to activate K⁺-induced dilation.²⁷ In the canine kidney, elevation of plasma [K⁺] to 10 mmol/L has been shown to increase renal blood flow (RBF) and glomerular filtration rate (GFR).²⁸ Similar effects of acute hyperkalemia on RBF and GFR have been reported in conscious sheep²⁹ and in rats³⁰ and rabbits.³¹ Although these investigations did not consider the possible role of Kir, our finding that elevated K⁺ promotes afferent arteriolar vasodilation through Kir is consistent with the observed increase in RBF and GFR.

By modulating glomerular inflow resistance, the afferent arteriole regulates glomerular capillary pressure and GFR when renal perfusion pressure is altered. Pressure-induced afferent vasoconstriction mediates this effect. Our observation that Kir is a major determinant of RMP in this vessel prompted an investigation into the possible involvement of Kir in myogenic signaling. Our findings do not support this postulate. Thus, although Ba²⁺ elicited membrane depolarization and vasoconstriction at low pressure, it did not prevent elevations in RAP from causing additional vasoconstriction. These data agree with findings from Kir2.1 knockout mice.²³ In this model, cerebral arteries showed normal myogenic reactivity but no K⁺-induced dilation. The observed changes in myogenic responses, including a leftward shift in the myogenic threshold, likely reflect the increase in basal tone and more positive RMP in the presence of Ba²⁺.

Defining the determinants of RMP under physiological conditions is of critical importance in regard to potential activation mechanisms. Agonists have been shown to inhibit specific K⁺ channels in isolated myocytes.^{10 11 12} However, such mechanisms could contribute to physiological responses only if the affected K⁺ channel contributes to RMP in the intact setting. The model we used allowed direct assessment of RMP and contractions in the intact afferent arteriole in situ under physiological conditions in regard to perfusion and transmural pressure. Our findings clearly indicate that Kir is a primary determinant of RMP under these conditions. Our model requires the induction of hydronephrosis to visualize the microvasculature. This preparation is well characterized and exhibits responses that are not only comparable to those observed using other renal microvascular models^{8 32} but also similar to those of the normal, intact kidney.^{16 33} Thus, there is no indication that hydronephrosis alters vascular K⁺ channel expression. Nevertheless, this possibility cannot be excluded. As described above, K⁺-induced vasodilation is observed in the normal kidney,^{28 29 30 31} but the role of Kir in this response has not been investigated. Moreover, barium-sensitive K⁺ currents have not been studied in myocytes or endothelial cells of the afferent arteriole. Information on the expression and regulation of Kir in this vessel would be of major interest.

In conclusion, this study provides the first functional evidence for Kir in renal afferent arterioles. Our findings suggest that Kir is a major determinant of in situ RMP and resting tone in this vessel. Accordingly, alterations in Kir activity or expression would likely impact on renal microvascular reactivity and could contribute to physiological or pathophysiological alterations in renal hemodynamics.

	Acknowledgments

 
This study supported by grants from the Canadian Institutes for Health Research and the Alberta Heritage Foundation for Medical Research (AHFMR). R.L. is an AHFMR Senior Medical Scholar, and L.C. is an Honorary Killam Scholar. The authors wish to thank Dr Wayne Giles and Dr William Cole for their comments and suggestions.

	Footnotes

 
Original received November 2, 2000; revision received November 28, 2000; accepted November 29, 2000.

	References

Top Abstract Introduction Materials and Methods Results Discussion References

 

1. Hirst GDS, Edwards FR. Sympathetic neuroeffector transmission in arteries and arterioles. Physiol Rev. 1989;69:546–604.[Free Full Text]
2. Quayle JM, McCarron JG, Brayden JE, Nelson MT. Inward rectifier K⁺ currents in smooth muscle cells from rat resistance-sized cerebral arteries. Am J Physiol. 1993;265:C1363–C1370.[Abstract/Free Full Text]
3. Quayle JM, Dart C, Standen NB. The properties and distribution of inward rectifier potassium currents in pig coronary arterial smooth muscle. J Physiol. 1996;494:715–726.[Medline] [Order article via Infotrieve]
4. Hirst GDS, Neild TO. An analysis of excitatory junctional potentials recorded from arterioles. J Physiol. 1978;280:87–104.[Abstract/Free Full Text]
5. Keatinge WR. Mechanism of slow discharges of sheep carotid artery. J Physiol. 1978;279:275–289.[Abstract/Free Full Text]
6. Knot HJ, Zimmermann PA, Nelson MT. Extracellular K⁺-induced hyperpolarizations and dilatations of rat coronary and cerebral arteries involve inward rectifier K⁺ channels. J Physiol. 1996;492:419–430.[Medline] [Order article via Infotrieve]
7. Prior HM, Webster N, Quinn K, Beech DJ, Yates MS. K⁺-induced dilation of a small renal artery: no role for inward rectifier K⁺ channels. Cardiovasc Res. 1998;37:780–790.[Abstract/Free Full Text]
8. Navar LG, Inscho EW, Majid DSA, Imig JD, Harrison-Benard LM, Mitchell KD. Paracrine regulation of the renal microcirculation. Physiol Rev. 1996;76:425–536.[Abstract/Free Full Text]
9. Haddy FJ, Scott JB. Metabolically linked vasoactive chemicals in local regulation of blood flow. Physiol Rev. 1968;48:688–707.[Free Full Text]
10. Nelson MT, Quayle JM. Physiological roles and properties of potassium channels in arterial smooth muscle. Am J Physiol. 1995;268:C799–C822.[Abstract/Free Full Text]
11. Cole WC, Clément-Chomienne O. Properties, regulation, and role of potassium channels of smooth muscle. In: Barr L, Christ GJ, eds. Advances in Organ Biology. Stamford, Conn: JAI Press Inc; 2000:247–317.
12. Quayle JM, Nelson MT, Standen NB. ATP-sensitive, and inwardly rectifying potassium channels in smooth muscle. Physiol Rev. 1997;77:1165–1232.[Abstract/Free Full Text]
13. Lopatin AN, CG Nichols. [K⁺] dependence of polyamine-induced rectification in inward rectifier potassium channels (IRK1, Kir2.1). J Gen Physiol. 1996;108:105–113.[Abstract/Free Full Text]
14. McCarron JG, Halpern W. Potassium dilates rat cerebral arteries by two independent mechanisms. Am J Physiol. 1990;259:H902–H908.[Abstract/Free Full Text]
15. Barrett-Jolley R, Dart C, Standen NB. Direct block of native and cloned (Kir2.1) inward rectifier K⁺ channels by chloroethylclonidine. Br J Pharmacol. 1999;128:760–766.[Medline] [Order article via Infotrieve]
16. Tang L, Loutzenhiser R. Biphasic actions of PGE₂ on the renal afferent arteriole. Circ Res. 2000;86:663–670.[Abstract/Free Full Text]
17. Loutzenhiser R, Chilton L, Trottier G. Membrane potential measurements in renal afferent and efferent arterioles: actions of angiotensin II. Am J Physiol. 1997;273:F307–F314.[Abstract/Free Full Text]
18. Loutzenhiser R, Parker M. Hypoxia inhibits myogenic reactivity of renal afferent arterioles by activating ATP-sensitive potassium channels. Circ Res. 1994;74:861–869.[Abstract/Free Full Text]
19. Johnson TD, Marrelli SP, Steenberg ML, Childres WF, Bryan RM Jr. Inward rectifier potassium channels in the rat middle cerebral artery. Am J Physiol. 1998;274:R541–R547.[Abstract/Free Full Text]
20. Hirst GDS, Silverberg GD, van Helden DF. The action potential and underlying ionic currents in proximal rat middle cerebral arterioles. J Physiol. 1986;371:289–304.[Abstract/Free Full Text]
21. Edwards FR, Hirst GDS, Silverberg GD. Inward rectification in rat cerebral arterioles; involvement of potassium ions in autoregulation. J Physiol. 1988;404:455–466.[Abstract/Free Full Text]
22. Robertson BE, Bonev AD, Nelson MT. Inward rectifier K⁺ currents in smooth muscle cells from rat coronary arteries: block by Mg²⁺, Ca²⁺, and Ba²⁺. Am J Physiol. 1996;271:H696–H705.[Abstract/Free Full Text]
23. Zaritsky JJ, Eckman DM, Wellman GC, Nelson MT, Schwarz TL. Targeted disruption of Kir2.1 and Kir2.2 genes reveals the essential role of the inwardly rectifying K⁺ current in K⁺-mediated vasodilation. Circ Res. 2000;87:160–166.[Abstract/Free Full Text]
24. Docherty JR, O’Rourke M. The -adrenoceptor-mediated actions of chloroethylclonidine. Gen Pharmacol. 1997;28:197–201.[Medline] [Order article via Infotrieve]
25. Kurtz A, Penner R. Angiotensin II induces oscillations of intracellular calcium and blocks anomalous inward rectifying potassium current in mouse renal juxtaglomerular cells. Proc Natl Acad Sci U S A. 1989;86:3423–3427.[Abstract/Free Full Text]
26. Syková E. Extracellular K⁺ accumulation in the central nervous system. Prog Biophys Molec Biol. 1983;42:135–189.[Medline] [Order article via Infotrieve]
27. Weiss JN, Lamp ST, Shine KI. Cellular K⁺ loss and anion efflux during myocardial ischemia and metabolic inhibition. Am J Physiol. 1989;256:H1165–H1175.[Abstract/Free Full Text]
28. Scott J, Emanuel D, Haddy F. Effect of potassium on renal vascular resistance and urine flow rate. Am J Physiol. 1959;197:305–308.
29. Budtz-Olsen OE, Clark RC, Cross RB, French TJ. Changes in renal haemodynamics and electrolyte excretion during acute hyperkalemia in conscious adrenectomized sheep. Quart J Exp Physiol Cog Med Sci. 1975;60:207–221.
30. Paller MS, Linas SL. Hemodynamic effects of alterations in potassium. Hypertension. 1982;4:III-20–III-26.
31. Lin H, Young DB. Impaired control of renal hemodynamics and renin release during hyperkalemia in rabbits. Am J Physiol. 1988;254:F704–F710.[Abstract/Free Full Text]
32. Loutzenhiser R. In situ studies of renal arteriolar function using the in vitro perfused hydronephrotic rat kidney. Int Rev Exp Pathol. 1996;36:145–160.[Medline] [Order article via Infotrieve]
33. Cupples WA, Loutzenhiser R. Dynamic autoregulation in the in vitro perfused hydronephrotic rat kidney. Am J Physiol. 1998;275:F126–F130.[Abstract/Free Full Text]

This article has been cited by other articles:

				X. Wang, K. Takeya, P. I. Aaronson, K. Loutzenhiser, and R. Loutzenhiser Effects of amiloride, benzamil, and alterations in extracellular Na+ on the rat afferent arteriole and its myogenic response Am J Physiol Renal Physiol, July 1, 2008; 295(1): F272 - F282. [Abstract] [Full Text] [PDF]

				C. M. Troncoso Brindeiro, R. W. Fallet, P. H. Lane, and P. K. Carmines Potassium channel contributions to afferent arteriolar tone in normal and diabetic rat kidney Am J Physiol Renal Physiol, July 1, 2008; 295(1): F171 - F178. [Abstract] [Full Text] [PDF]

				L. Chilton, K. Loutzenhiser, E. Morales, J. Breaks, G. J. Kargacin, and R. Loutzenhiser Inward Rectifier K+ Currents and Kir2.1 Expression in Renal Afferent and Efferent Arterioles J. Am. Soc. Nephrol., January 1, 2008; 19(1): 69 - 76. [Full Text] [PDF]

				C. Cao, W. Lee-Kwon, K. Payne, A. Edwards, and T. L. Pallone Descending vasa recta endothelia express inward rectifier potassium channels Am J Physiol Renal Physiol, October 1, 2007; 293(4): F1248 - F1255. [Abstract] [Full Text] [PDF]

				X. Wang, J. Breaks, K. Loutzenhiser, and R. Loutzenhiser Effects of inhibition of the Na+/K+/2Cl- cotransporter on myogenic and angiotensin II responses of the rat afferent arteriole Am J Physiol Renal Physiol, March 1, 2007; 292(3): F999 - F1006. [Abstract] [Full Text] [PDF]

				Y. Sun, M. Chen, B. H. Lowentritt, P. S. Van Zijl, K. R. Koch, S. Keay, J. M. Simard, and T. C. Chai EGF and HB-EGF modulate inward potassium current in human bladder urothelial cells from normal and interstitial cystitis patients Am J Physiol Cell Physiol, January 1, 2007; 292(1): C106 - C114. [Abstract] [Full Text] [PDF]

				M. A. Machingal and S. V. Ramanan A Steady-State Electrochemical Model of Vascular Smooth Muscle Cells Biophys. J., September 1, 2006; 91(5): 1648 - 1662. [Abstract] [Full Text] [PDF]

				R. Loutzenhiser Inward rectifier currents in pericytes Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2006; 290(6): R1598 - R1600. [Full Text] [PDF]

				K. Matsushita and D. G. Puro Topographical heterogeneity of KIR currents in pericyte-containing microvessels of the rat retina: effect of diabetes J. Physiol., June 1, 2006; 573(2): 483 - 495. [Abstract] [Full Text] [PDF]

				C. Cao, J. H. Goo, W. Lee-Kwon, and T. L. Pallone Vasa recta pericytes express a strong inward rectifier K+ conductance Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2006; 290(6): R1601 - R1607. [Abstract] [Full Text] [PDF]

				X. Wang, M. D. Hollenberg, and R. Loutzenhiser Redundant signaling mechanisms contribute to the vasodilatory response of the afferent arteriole to proteinase-activated receptor-2 Am J Physiol Renal Physiol, January 1, 2005; 288(1): F65 - F75. [Abstract] [Full Text] [PDF]

				T. L. Pallone, C. Cao, and Z. Zhang Inhibition of K+ conductance in descending vasa recta pericytes by ANG II Am J Physiol Renal Physiol, December 1, 2004; 287(6): F1213 - F1222. [Abstract] [Full Text] [PDF]

				T. Takenaka, Y. Ohno, K. Hayashi, T. Saruta, and H. Suzuki Governance of arteriolar oscillation by ryanodine receptors Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2003; 285(1): R125 - R131. [Abstract] [Full Text] [PDF]

				T. Karkanis, S. Li, J. G. Pickering, and S. M. Sims Plasticity of KIR channels in human smooth muscle cells from internal thoracic artery Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H2325 - H2334. [Abstract] [Full Text] [PDF]

				R. Loutzenhiser, A. Bidani, and L. Chilton Renal Myogenic Response: Kinetic Attributes and Physiological Role Circ. Res., June 28, 2002; 90(12): 1316 - 1324. [Abstract] [Full Text] [PDF]

				D. M. Eckman and M. T. Nelson Potassium Ions as Vasodilators: Role of Inward Rectifier Potassium Channels Circ. Res., February 2, 2001; 88(2): 132 - 133. [Full Text] [PDF]

				X. Wang and R. Loutzenhiser Determinants of renal microvascular response to ACh: afferent and efferent arteriolar actions of EDHF Am J Physiol Renal Physiol, January 1, 2002; 282(1): F124 - F132. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions